CSNK2B and hepatocellular carcinoma: For example, overexpression of CSNK2B has been found to activate the NF-κB signaling in hepatocellular carcinoma (HCC), thus promoting cell proliferation and inhibiting cell apoptosis of HCC (Xiao et al. 2020).